Last Updated: May 11, 2026

Profile for Ukraine Patent: 108980


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Ukraine Patent: 108980

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,410,167 Apr 16, 2029 Sanofi Aventis Us MULTAQ dronedarone hydrochloride
9,107,900 Apr 16, 2029 Sanofi Aventis Us MULTAQ dronedarone hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Ukraine Patent UA108980

Last updated: August 9, 2025


Introduction

Ukraine Patent UA108980 pertains to a specific pharmaceutical innovation, likely related to a novel drug formulation or method of use, given typical patent classifications. An in-depth examination of its scope, claims, and the broader patent landscape offers critical insights into its enforceability, competitive positioning, and potential for licensing or further development.


Patent Summary

Patent Number: UA108980
Filing Date: (Assumed date based on Ukrainian patent databases; precise date not provided here)
Grant Date: (Likewise, specific date unavailable without access to Ukrainian Patent Office records)
Patent Title: (Exact title not specified, but presumed to be a medicinal or pharmaceutical patent)
Inventor(s): (Details not supplied)
Applicant/Assignee: (Details not supplied)

UA108980 appears to cover a pharmaceutical compound, formulation, or method of therapy—common in Ukrainian patents within the biotech and pharmaceuticals sector. Its scope hinges on the claims, which define the pharmaceutical innovation's boundaries.


Claims Analysis

1. Types of Claims

The claims in Ukrainian pharmaceutical patents generally encompass:

  • Compound Claims: Cover specific chemical entities or compositions.
  • Use Claims: Coverment of specific therapeutic applications or methods of use.
  • Process Claims: Methods of manufacturing or preparing the compound.
  • Formulation Claims: Specific dosage forms, excipients, or delivery mechanisms.

Assuming UA108980 aligns with typical coverage, it likely contains a combination of these claim types, establishing the foundation of patent protection.

2. Primary Claims Focus

Without direct access to the patent text, the following analysis is based on standard pharmaceutical patent practices:

  • Compound Claims: If the patent covers a novel chemical entity (NCE), the claims specify the chemical structure with marked structural limitations.
  • Use Claims: These probably specify therapeutic applications—e.g., “the use of compound X for treating disease Y.”
  • Method Claims: Techniques for synthesizing the compound or administering the dosage.

3. Claim Breadth and Specificity

The breadth of claims is critical for patent robustness:

  • Broad Claims: Encompass the entire class of compounds sharing a core structure, offering extensive protection but potentially facing validity challenges if overly broad.
  • Dependent or Narrower Claims: Focus on specific derivatives, formulations, or specific methods, reducing infringement risk but providing narrower scope.

In Ukrainian practice, claim language usually balances breadth with sufficient novelty and inventive step support.


Patent Landscape in Ukraine for Pharmaceutical Drugs

1. Ukrainian Patent System Overview

Ukraine adheres to the Paris Convention and the Patent Cooperation Treaty (PCT), facilitating pharmaceutical patent applications. Pharmaceutical patents are governed by the Law of Ukraine "On Patents for Inventions," with specific provisions for biotechnological and pharmaceutical inventions.

2. Existing Patent Landscape

  • Prevalent Players: Ukrainian and European companies dominate, with some international pharmaceutical firms securing patents or licenses.
  • Patent Family Extensions: Many Ukrainian patents are part of broader family portfolios extending from European or US filings.
  • Saturation of Similar Compounds: The landscape includes numerous patents on similar chemical entities or therapeutic methods, creating a competitive environment.

3. Patent Clearance and Freedom-to-Operate

Given the complex landscape, clearance requires thorough patent searches in neighboring jurisdictions, considering potential overlapping claims or equivalents. Patent expiration timelines also influence the market potential, with the typical 20-year term from filing.

4. Prior Art and Patent Validity

Prior art in Ukraine and Eurasian patent databases suggests the necessity for precise claim drafting—narrower claims may mitigate invalidity risks posed by earlier disclosures.


Scope of Patent UA108980

1. Whether the Patent is Broad or Narrow

  • If UA108980 discloses a specific chemical compound, its protection might be limited to that compound or its analogs explicitly disclosed.
  • A broader use or method claim may cover related treatment methods, increasing enforceability.
  • The scope depends on the claim language precision and whether it includes derivatives or equivalents.

2. Patent Term and Exclusivity

  • Likely valid for 20 years from the filing date, subject to maintenance fees.
  • The scope's relevance diminishes as newer patents emerge or if generic manufacturers develop around narrow claims.

3. Possible Limitations

  • Lack of priority claim or insufficient disclosure may weaken the patent scope.
  • If claims are too broad without supporting data, they risk invalidity.

Claims Landscape and Strategic Positioning

1. Comparative Analysis with International Patents

  • Novelty: Ukrainian patent law requires that the claimed invention is new and inventive over prior art.
  • Inventive Step: The patent’s claims should demonstrate an inventive step over existing Ukrainian patents, European patents (EP), and other global publications.

2. Overlap With Existing Patents

  • European and US patents on similar compounds are common; however, Ukrainian patents often focus on local markets or specific formulations.
  • The patent landscape shows a trend toward filing regional patents to secure market exclusivity within Eastern Europe.

3. Enforceability and Litigation Risks

  • Enforceability depends on clear claim language and patent prosecution quality.
  • US and European patents are often better characterized, while UA108980’s strength depends on detailed claim support and validity assessments.

Patent Landscape Trends in Ukraine

  • Increased filings for biologics, formulations, and combination therapies.
  • Growing emphasis on patent quality, with stricter examination procedures aligning with international standards.
  • Collaboration with international patent offices improves patent landscape transparency and validity.

Conclusion

UA108980 embodies a strategic patent that potentially covers a specific pharmaceutical compound or method of use within Ukraine's legal framework. Its scope's strength primarily depends on claim breadth and validity over prior art. The Ukrainian patent landscape is dynamic, emphasizing innovation but also challenges from prior disclosures and regional patent conflicts.


Key Takeaways

  • Claim Specificity is Crucial: Narrow, well-supported claims enhance enforceability and reduce invalidity risks.
  • Patent Strategy Should Consider Regional Competition: A robust patent portfolio aligns with local and international patent rights.
  • Patent Validity Depends on Prior Art: Thorough patent searches are essential to validate scope and strength.
  • Monitor Patent Expiration: Identifying upcoming expirations provides market entry opportunities.
  • Alignment with International IP Laws: Careful drafting within Ukraine’s legal standards ensures durability and enforceability.

FAQs

1. What is the typical scope of pharmaceutical patents like UA108980 in Ukraine?
Pharmaceutical patents in Ukraine generally protect specific chemical compounds, their methods of synthesis, and therapeutic uses. The scope varies based on claim language, with narrower claims offering targeted protection and broader claims risking invalidity.

2. How does Ukrainian patent law influence the scope of pharmaceutical patents?
Ukraine’s patent law mandates novelty, inventive step, and industrial applicability. Claims must be specific, well-supported, and not overly broad to withstand legal challenges, shaping the scope and enforceability of patents.

3. What competitive risks exist if UA108980’s claims are too broad?
Overly broad claims may face invalidation due to prior art or lack of inventive step, thus weakening market exclusivity. They also risk infringement by subsequent innovations or generic entrants.

4. How does the Ukrainian patent landscape impact global pharmaceutical patent strategies?
Ukrainian patents often form part of regional strategies, emphasizing local market protection. Companies seek to complement their larger portfolio filings elsewhere, considering local innovation, therapeutic needs, and legal standards.

5. What key factors determine the enforceability of UA108980?
Claim clarity, validity over prior art, proper claim support, and compliance with procedural regulations are essential to enforceability within Ukraine's legal framework.


References
[1] Ukrainian Law “On Patents for Inventions.”
[2] Ukrainian Patent Office official publications.
[3] Trends in European and international pharmaceutical patent filings.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.